Ziopharm Oncology (ZIOP) Misses Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq set for sharp drop as Amazon, Intel amplify AI spending worries
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Tweet
Share
E-mail
Get Alerts ZIOP Hot Sheet
Price: $0.87 --0%
Financial Fact:
Loss from operations: -10.91M
Today's EPS Names:
BNCC, ZVOI, SYRS, More
Financial Fact:
Loss from operations: -10.91M
Today's EPS Names:
BNCC, ZVOI, SYRS, More
Join SI Premium – FREE
Ziopharm Oncology (NASDAQ: ZIOP) reported Q4 EPS of ($0.09), $0.01 worse than the analyst estimate of ($0.08).
For earnings history and earnings-related data on Ziopharm Oncology (ZIOP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Why Beijing could block the SpaceX-Tesla merger
- Arbor Realty Trust (ABR) Misses Q3 EPS by 8c
- Regal-Beloit (RBC) Tops Q3 EPS by 21c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
